Exchange: NYSE·Updated 07:48 PM EDT

IQV News

News
all
press releases
IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know
IQV's accelerating organic growth, robust R&DS bookings and expanding AI adoption are strengthening demand visibility and business momentum.
Zacks
IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know
IQV's accelerating organic growth, robust R&DS bookings and expanding AI adoption are strengthening demand visibility and business momentum.
Zacks
More News
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Why Is NeuroPace (NPCE) Down 0.4% Since Last Earnings Report?
NeuroPace (NPCE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
IQVIA Announces Pricing of Senior Notes
IQVIA Holdings Inc. (IQVIA) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the Issuer), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2034 (the Notes). The proceeds from the Notes offering will be used to redeem in full the Issuers...
Business Wire
IQVIA Announces Offering of Senior Notes
IQVIA Holdings Inc. (IQVIA) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the Issuer), intends to raise $2,000,000,000 through an offering of senior notes due 2034 (the Notes). The proceeds from the Notes offering will be used to redeem in full the Issuers Senior 5.000...
Business Wire
IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to...
Business Wire
VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast
Veeva raises its fiscal 2027 outlook as Vault CRM adoption, R&D growth and Falcon AI momentum support expanding revenue and profitability.
Zacks
Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help...
Business Wire
Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks

Advertisement|Remove ads.